The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Abbott's Ibis Technology Identified Fatal Disease Organism in Afghanistan

February 7, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Feb. 7, 2011 /- Today, at the American Society for Microbiology Conference on Biodefense and Emerging Diseases, scientists from Abbott Molecular presented data showing the unique power of the company's Ibis technology to identify and further characterize unknown...


Hydrocodone Bitartrate And Acetaminophen Tablets, Phenobarbital Tablets by Qualitest: Recall - Incorrect Package Labeling

February 7, 2011 9:30 am | by U.S. Food & Drug Administration | News | Comments

Patients may unintentionally take Hydrocodone and acetaminophen tablets, instead of the intended dose of Phenobarbital, which can lead to serious adverse events.


Egypt Today; The Muslim Brotherhood; The Jobs Numbers and Obama in

February 7, 2011 8:45 am | by Chris MatthewsAssociated Press | News | Comments

xfdls HARDBALL-01

Summary Box: Humana's 4Q net income falls 57 pct

February 7, 2011 7:45 am | by The Associated Press | News | Comments

THE RESULTS: Humana Inc.'s fourth-quarter net income fell 57 percent to $107.3 million, or 63 cents per share, weighed down by $1.02 per share of expenses. Revenue rose 9.4 percent to $8.35 billion.ENROLLMENT GAINS: Humana's Medicare Advantage membership increased to approximately 1.89 million in...

FDA Orders Postmarket Surveillance of Certain TMJ Implants

February 7, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Feb. 7, 2011 /PRNewswire-USNewswire/ -- Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint (TMJ) implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or...


CURE Magazine Teams Up With Amgen Oncology and Breakaway from Cancer® to Launch 2011 Extraordinary Healer Award for Oncology Nursing

February 7, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

DALLAS and THOUSAND OAKS, Calif., Feb. 7, 2011 /- For the fifth consecutive year, CURE magazine is calling on cancer patients, survivors and caregivers from across the country to submit essays for the 2011 Extraordinary Healer Award for Oncology Nursing . The contest, made possible with...


Abbott Introduces Biothreat Assay for PLEX-IDâ„¢ System

February 7, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Feb. 7, 2011 /- Abbott (NYSE: ABT ) announced today that it has introduced the PLEX-ID™ Biothreat Assay, which is designed to detect and distinguish 17 different biothreat pathogens.  This assay enables rapid and accurate detection of potentially dangerous...


Prize4Life gives $1M ALS award to Mass. doctor, entrepreneur

February 7, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Prize4Life, a Cambridge non-profit focused on advancing research into cures for ALS, has awarded a prize of $1 million to Dr. Seward Rutkove for his discovery of a new biomarker for ALS.


Expanding drug development horizons: Receptor behaviors observed in living cell membranes

February 7, 2011 5:36 am | by EurekAlert | News | Comments

(Institute for Integrated Cell-Material Sciences, Kyoto University) Unprecedented single molecule imaging movies of living cell membranes, taken by a research team based at Kyoto University and the University of New Mexico, have clarified a decades-old enigma surrounding receptor...


Danaher agrees to buy Beckman Coulter for $5.87B

February 7, 2011 4:45 am | by The Associated Press | News | Comments

Medical and industrial instruments maker Danaher Corp. said Monday it agreed to buy medical testing instrument maker Beckman Coulter for about $5.87 billion.Beckman Coulter Inc. makes products that simplify and automate biomedical testing. It will become part of Danaher's life sciences and...

Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Contact Cooling System for Aesthetic Use

February 7, 2011 4:36 am | by U.S. Food & Drug Administration | News | Comments

This guidance document was developed as a special control guidance to support the classification of the contact cooling system for aesthetic use into class II (special controls). The device is intended to apply cooling to the body to achieve temporary...

Federal Register: Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting

February 7, 2011 4:35 am | by U.S. Food & Drug Administration | News | Comments

On March 8 and 9, 2011, the committee will discuss and make recommendations on scientific issues concerning direct to consumer (DTC) genetic tests that make medical claims.

Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference

February 7, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

MYSTIC, Conn. and DUBLIN, Feb. 7, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ) today announced that it is scheduled to participate in the Leerink Swann Hot Topics in Therapeutics Roundtable Conference on Wednesday, February 16, 2011. Amarin's participation includes both a panel...


UrgentRx Launches Line of Innovative and Portable, Fast-Acting Medications Across Colorado

February 7, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

DENVER, Feb. 7, 2011 /- Colorado start-up, UrgentRx , today announced the launch of a new line of fast-acting, powdered medications in convenient credit card-sized packets, including UrgentRx Aspirin to Go , a life-saving product specifically developed as heart attack first aid....



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.